Novartis AG
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Novartis AG's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10% to $46,660,000,000. The net income raised on $14,850,000,000 and profit margin reached 32%. Total operating expenses were $24,419,000,000.
Profit Margin
| 2014 | 53.63B | 10.21B | 19.04% |
|---|---|---|---|
| 2015 | 50.38B | 17.78B | 35.29% |
| 2016 | 49.43B | 6.71B | 13.58% |
| 2017 | 50.13B | 7.70B | 15.36% |
| 2018 | 53.16B | 12.61B | 23.72% |
| 2019 | 48.67B | 7.14B | 14.68% |
| 2020 | 49.89B | 8.07B | 16.18% |
| 2021 | 52.87B | 24.02B | 45.43% |
| 2022 | 51.82B | 6.95B | 13.42% |
| 2023 | 46.66B | 14.85B | 31.83% |
NOVN.SW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 46.66B | 51.82B | 52.87B | 49.89B | 48.67B | 53.16B | 50.13B | 49.43B | 50.38B | 53.63B |
Cost of revenue | 12.47B | 15.48B | 15.86B | 15.12B | 14.42B | 18.40B | 17.17B | 17.52B | 17.40B | 17.34B |
Gross profit | 34.18B | 36.34B | 37.01B | 34.77B | 34.25B | 34.75B | 32.96B | 31.91B | 32.98B | 36.28B |
Operating exp. | ||||||||||
Research and development | 11.37B | 9.99B | 9.54B | 8.98B | 9.40B | 9.07B | 8.97B | 9.03B | 8.93B | 9.08B |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 12.86B | 11.99B | 11.77B | 12.37B |
Total operating expenses | 24.41B | 27.14B | 25.32B | 24.62B | 25.16B | 26.59B | 24.33B | 23.64B | 24.00B | 25.2B |
Operating income | 9.76B | 9.19B | 26.94B | 10.15B | 9.08B | 8.16B | 8.62B | 8.26B | 8.97B | 11.08B |
Other income (expenses), net | -646M | -826M | -811M | -274M | -146M | 6.37B | 400M | 233M | -843M | 1.18B |
Income before tax | 9.12B | 8.37B | 26.13B | 9.87B | 8.94B | 13.83B | 8.99B | 7.81B | 8.13B | 12.27B |
Income tax expense | 551M | 1.41B | 2.11B | 1.80B | 1.79B | 1.22B | 1.29B | 1.11B | 1.10B | 1.54B |
Net income | 14.85B | 6.95B | 24.02B | 8.07B | 7.14B | 12.61B | 7.70B | 6.71B | 17.78B | 10.21B |
Earnings per share | ||||||||||
Basic EPS | 7.11 | 3.19 | 10.71 | 3.55 | 3.12 | 5.44 | 3.28 | 2.82 | 7.4 | 4.21 |
Diluted EPS | 7.1 | 3.17 | 10.63 | 3.52 | 3.08 | 5.38 | 3.25 | 2.8 | 7.29 | 4.13 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |